Candel Therapeutics initiated with a Buy at BofA
BofA initiated coverage of Candel Therapeutics (CADL) with a Buy rating and $15 price target Candel’s pipeline includes two lead drugs – ...
Windows PowerToys: Your handy productivity toolbox
To access PowerToys settings, tools, and info, click its icon in the notification area at the right-hand side of the Windows ...
Power Integrations Reports Fourth-Quarter and Full-Year Financial Results
Power Integrations (NASDAQ: POWI) today announced financial results for the quarter and year ended December 31, 2024. Net revenues for the fourth quarter were $105.2 ...